logo-loader

Hikma Pharmaceuticals plc.

Receive alerts
Market:
AIM
Market Cap:
£4.64 billion
Price
1,914.00 GBX
Change
1.30%
52 weeks high
2212.00
52 weeks low
1491.50

In brief

Hikma Pharmaceuticals PLC is a pharmaceutical company engaged the development, manufacture and marketing of a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.